当前位置: 首页 > 期刊 > 《湖南中医学院学报》 > 20195
编号:13552214
泽泻汤加味方通过AT1R通路抑制高盐和AngII诱导HBZY-1中NOX4表达的研究(5)
http://www.100md.com 2019年5月1日 《湖南中医药大学学报》 20195
     [17] WOLAK T, ALIEV E, ROGACHEV B, et al. Renal safety and angiogenesis II blockade medications in patients undergoing non-emergent coronary angiography: A randomized controlled study[J]. The Israel Medical Association Journal, 2013,5(11):682-687.

    [18] TUCKER S, CHEN Y, ABELL R. In patients with chronic diabetic nephropathy, do angiotensin converting enzyme inhibitors (ACEI) have greater renal protective effect as compared to angiotensin receptor blockers (ARB)?[J]. Journal of the Oklahoma State Medical Association, 2013,106(7):294-295.

    [19] KURDI M, BOOZ G W. New take on the role of angiotensin II in cardiac hypertrophy and fibrosis[J]. Hypertension, 2011, 57(6):1034-1038.

    [20] LI T B, ZHANG Y Z, LIU W Q, et al. Correlation between NADPH oxidase-mediated oxidative stress and dysfunction of endothelial progenitor cell in hyperlipidemic patients[J]. Korean Journal of Internal Medicine, 2017, 33(2):313-322.

    [21] 陳景彦,陈炳宏,张树峰,等.泽泻汤加味方对高盐高血压大鼠的降压疗效及对肾功能的保护作用[J].中国老年学杂志,2012,32(24):5467-5469.

    [22] TASHIRO Y, YOGO K, SERIZAWA K, et al. Nicorandil suppresses urinary protein excretion and activates eNOS in Dahl salt-sensitive hypertensive rats[J]. Clinical & Experimental Nephrology, 2015, 19(3):343-349., http://www.100md.com(刘凯 赵娟 刘玉玲 崔海鹏 董雅洁 卢锴锋 孙晓旭 王途 张树峰)
上一页1 2 3 4 5